GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Marrone Bio Innovations Inc (NAS:MBII) » Definitions » EPS without NRI

Marrone Bio Innovations (Marrone Bio Innovations) EPS without NRI : $-0.12 (TTM As of Mar. 2022)


View and export this data going back to 2013. Start your Free Trial

What is Marrone Bio Innovations EPS without NRI?

Marrone Bio Innovations's earnings per share without non-recurring items for the three months ended in Mar. 2022 was $-0.04. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2022 was $-0.12.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 23.40% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 41.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Marrone Bio Innovations's EPS without NRI or its related term are showing as below:

MBII' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 7.2   Med: 35   Max: 51.8
Current: 23.4

During the past 11 years, Marrone Bio Innovations's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 51.80% per year. The lowest was 7.20% per year. And the median was 35.00% per year.

MBII's 3-Year EPS without NRI Growth Rate is not ranked
in the Agriculture industry.
Industry Median: 16.6 vs MBII: 23.40

Marrone Bio Innovations's EPS (Diluted) for the three months ended in Mar. 2022 was $-0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was $-0.12.

Marrone Bio Innovations's EPS (Basic) for the three months ended in Mar. 2022 was $-0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2022 was $-0.12.


Marrone Bio Innovations EPS without NRI Historical Data

The historical data trend for Marrone Bio Innovations's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marrone Bio Innovations EPS without NRI Chart

Marrone Bio Innovations Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.06 -0.20 -0.32 -0.14 -0.09

Marrone Bio Innovations Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.02 -0.03 -0.03 -0.04

Competitive Comparison of Marrone Bio Innovations's EPS without NRI

For the Agricultural Inputs subindustry, Marrone Bio Innovations's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marrone Bio Innovations's PE Ratio without NRI Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Marrone Bio Innovations's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Marrone Bio Innovations's PE Ratio without NRI falls into.



Marrone Bio Innovations EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marrone Bio Innovations  (NAS:MBII) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Marrone Bio Innovations EPS without NRI Related Terms

Thank you for viewing the detailed overview of Marrone Bio Innovations's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Marrone Bio Innovations (Marrone Bio Innovations) Business Description

Traded in Other Exchanges
N/A
Address
7780-420 Brier Creek Parkway,, Raleigh, NC, USA, 27617
Marrone Bio Innovations Inc is a US-based agricultural company engaged in the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition. The company produces bio-based pest management and plant health products such as Biopesticides, Bioinsecticides, Bionematicides, Biofungicides, Biostimulants and Bionutrition, among others. It generates key revenue from the sales of Marrone products, mainly Regalia, Grandevo and Venerate.
Executives
Pamela G Marrone director, officer: CEO and President C/O MARRONE BIO INNOVATIONS, INC., 2121 SECOND STREET, A-107, DAVIS CA 95618
Ladon Johnson officer: Interim CFO C/O MARRONE BIO INNOVATIONS, INC. 7780-420 BRIER CREEK PARWAY RALEIGH NC 27617-7882
Ardsley Ridgecrest Partners Fund, L.p. other: See Footnote (1) 262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Suping (sue) Cheung officer: Chief Financial Officer C/O QUICKLOGIC CORPORATION, SUNNYVALE CA 94089
Matti Tiainen officer: SVP, International Sales C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Lara L Lee director C/O MARRONE BIO INNOVATIONS, INC., 1540 DREW AVENUE, DAVIS CA 95618
Kevin Helash director, officer: Chief Executive Officer C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Ardsley Advisory Partners Gp Llc other: See Footnotes(1)(2) 262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Ospraie Management, Llc director, 10 percent owner, other: (See Remarks) 437 MADISON AVENUE, 28TH FLOOR, NEW YORK NY 10022
Ospraie Management, Inc. director, 10 percent owner, other: (See Remarks) 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ospraie Holding I, L.p. director, 10 percent owner, other: (See Remarks) 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Dwight Anderson director, 10 percent owner, other: (See Remarks) C/O OSPRAIE MANAGEMENT, LLC, 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ardsley Healthcare Fund, L.p. other: See Footnote (1) C/O ARDSLEY PARTNERS I GP, LLC, 262 HARBOR DRIVE, STAMFORD CT 06902
Ospraie Ag Science Llc director, 10 percent owner, other: (See Remarks) C/O DWIGHT ANDERSON 437 MADISON AVENUE, 28TH FLOOR NEW YORK NY 10022
Van Herk Investments B.v. 10 percent owner LICHTENAUERLAAN 30 ROTTERDAM P7 3062ME